Skip to main content Accessibility help
×
×
Home
  • Print publication year: 2010
  • Online publication date: August 2011

Chapter 10 - Magnetic resonance imaging to assess gray matter damage in multiple sclerosis

from Section 2 - Assessment of mechanisms and disease status
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Multiple Sclerosis
  • Online ISBN: 9780511781698
  • Book DOI: https://doi.org/10.1017/CBO9780511781698
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

1. BrownellB, HughesJ T. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315–20
2. KiddD, BarkhofF, McConnellR, et al. Cortical lesions in multiple sclerosis. Brain 1999;122:17–26
3. PetersonJ W, L, MorkS, ChangA, TrappB D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400
4. LumsdenG E. The neuropathology of multiple sclerosis. In: VinkenP J, BrunyG W, eds. Handbook of Clinical Neurology. Amsterdam: North-Holland, 1970:217–309
5. BoL, VedelerC A, NylandH I, TrappB D, MorkS J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropath Exp Neurol 2003;62:723–32
6. VercellinoM, PlanoF, VottaB, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005;64:1101–7
7. HuitingaI, De GrootC J, Van der ValkP, et al. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001;60:1208–18
8. GeurtsJ J, L, RoosendaalS D, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007;66:819–27
9. KutzelniggA, Faber-RodJ C, BauerJ, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17:38–44
10. GilmoreC P, BoL, OwensT, et al. Spinal cord gray matter demyelination in multiple sclerosis: a novel pattern of residual plaque morphology. Brain Pathol 2006;16:202–8
11. MagliozziR, HowellO, VoraA, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089–104
12. FilippiM, ValsasinaP, RoccaM A. Magnetic resonance imaging of grey matter damage in people with MS. Int MS J 2007;14:12–21
13. FilippiM, RoccaM A. Conventional MRI in multiple sclerosis. J Neuroimag 2007;17 (Suppl 1):3S–9S
14. FilippiM, YousryT A, BarattiC, et al. Quantitative assessment of MRI lesion load in multiple sclerosis: a comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 1996;119:1349–55
15. TubridyN, BarkerG J, MacManusD G, MoseleyI F, MillerD H. Three-dimensional fast fluid attenuated inversion recovery (3D fast FLAIR): a new MRI sequence which increases the detectable cerebral lesion load in multiple sclerosis. Br J Radiol 1998;71:840–5
16. BakshiR, AriyaratanaS, BenedictR H, JacobsL. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001;58:742–8
17. GeurtsJ J, PouwelsP J, UitdehaagB M, et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254–60
18. CalabreseM, De StefanoN, AtzoriM, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007;64:1416–22
19. NelsonF, PoonawallaA H, HouP, et al. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. Am J Neuroradiol 2007;28:1645–9
20. OrmerodI E, MillerD H, McDonaldW I, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987;110:1579–616
21. BakshiR, BenedictR H, BermelR A, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62–8
22. RoosendaalS D, MoraalB, VrenkenH, et al. In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging 2008; 27:726–31
23. KangarluA, BourekasE C, Ray-ChaudhuryA, RammohanK W. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. Am J Neuroradiol 2007;28:262–6
24. RovarisM, FilippiM, MinicucciL, et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. Am J Neuroradiol 2000;21:402–8
25. MoriartyD M, BlackshawA J, TalbotP R, et al. Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion recovery MR images. Am J Neuroradiol 1999;20:1956–62
26. CatalaaI, FultonJ C, ZhangX, et al. MR imaging quantitation of grey matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing. Am J Neuroradiol 1999;20:1613–18
27. FilippiM, AgostaF. Magnetization transfer MRI in multiple sclerosis. J Neuroimaging 2007;17(Suppl 1):22S–26S
28. CercignaniM, BozzaliM, IannucciG, ComiG, FilippiM. Magnetization transfer ratio and mean diffusivity of normal-appearing white and gray matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:311–17
29. GeY, GrossmanR I, UdupaJ K, et al. Magnetization transfer ratio histogram analysis of gray matter in relapsing–remitting multiple sclerosis. Am J Neuroradiol 2001;22:470–5
30. DehmeshkiJ, ChardD T, LearyS M, et al. The normal appearing gray matter in primary progressive multiple sclerosis: a magnetization transfer imaging study. J Neurol 2003;250:67–74
31. FernandoK T, TozerD J, MiszkielK A, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005;128:2911–25
32. DaviesG R, AltmannD R, HadjiprocopisA, et al. Increasing normal-appearing gray and white matter magnetization transfer ratio abnormality in early relapsing–remitting multiple sclerosis. J Neurol 2005;252:1037–44
33. Ramio-TorrentaL, Sastre-GarrigaJ, IngleG T, et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006;77:40–5
34. RovarisM, BozzaliM, SantuccioG, et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001;124:2540–9
35. RovarisM, JudicaE, Sastre-GarrigaJ, et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008;14:455–64
36. AudoinB, RanjevaJ P, Au DuongM V, et al. Voxel-based analysis of MTR images: a method to locate grey matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 2005;20:765–71
37. DaviesG R, AltmannD R, RashidW, et al. Emergence of thalamic magnetization transfer ratio abnormality in early relapsing–remitting multiple sclerosis. Mult Scler 2005;11:276–81
38. Oreja-GuevaraC, CharilA, CaputoD, et al. MT MRI reflects clinical changes over 18 months in relapsing–remitting MS patients. Arch Neurol 2006;63:736–40
39. RanjevaJ P, AudoinB, Au DuongM V, et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. Am J Neuroradiol 2005;26:119–27
40. CodellaM, RoccaM A, ColomboB, et al. A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue. J Neurol 2002;249:535–7
41. AgostaF, RovarisM, PaganiE, et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006;129:2620–7
42. RovarisM, GassA, BammerR, et al. Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526–32
43. BozzaliM, CercignaniM, SormaniM P, ComiG, FilippiM. Quantification of brain grey matter damage in different MS phenotypes by use of diffusion tensor MR imaging. Am J Neuroradiol 2002;23:985–8
44. RovarisM, BozzaliM, IannucciG, et al. Assessment of normal-appearing white and grey matter in patients with primary progressive multiple sclerosis. Arch Neurol 2002;59:1406–12
45. Oreja-GuevaraC, RovarisM, IannucciG, et al. Progressive grey matter damage in patients with relapsing–remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Arch Neurol 2005;62:578–84
46. PulizziA, RovarisM, JudicaE, et al. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Arch Neurol 2007;64:1163–8
47. FabianoA J, SharmaJ, Weinstock-GuttmanB, et al. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimag 2003;13:307–14
48. RovarisM, GalloA, ValsasinaP, et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. NeuroImage 2005;24:1139–46
49. RovarisM, JudicaE, GalloA, et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006;129:2628–34
50. RovarisM, IannucciG, FalautanoM, et al. Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci 2002;195:103–9
51. De StefanoN, FilippiM, MillerD, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology 2007;69:1942–52
52. SharmaR, NarayanaP A, WolinskyJ S. Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 2001;7:221–6
53. ChardD T, GriffinC M, McLeanM A, et al. Brain metabolite changes in cortical gray and normal-appearing white matter in clinically early relapsing–remitting multiple sclerosis. Brain 2002;125:2342–52
54. SarchielliP, PresciuttiO, TarducciR, et al. Localized 1H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. J Neurol 2002;249:902–10
55. AdalsteinssonE, Langer-GouldA, HomerR J, et al. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing–remitting multiple sclerosis. Am J Neuroradiol 2003;24:1941–5
56. CifelliA, ArridgeM, JezzardP, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650–3
57. IngleseM, LiuS, BabbJ S, et al. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing–remitting MS. Neurology 2004;63:170–2
58. KapellerP, BrexP A, ChardD T, et al. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2002;8:207–10
59. SijensP E, MostertJ P, OudkerkM, De KeyserJ. 1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Eur Radiol 2006;16:489–95
60. WylezinskaM, CifelliA, JezzardP, et al. Thalamic neurodegeneration in relapsing–remitting multiple sclerosis. Neurology 2003;60:1949–54
61. Sastre-GarrigaJ, IngleG T, ChardD T, et al. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 2005;62:569–73
62. MillerD H, BarkhofF, FrankJ A, ParkerG J, ThompsonA J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95
63. DaltonC M, ChardD T, DaviesG R, et al. Early development of multiple sclerosis is associated with progressive gray matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101–7
64. ChardD T, GriffinC M, ParkerG J, et al. Brain atrophy in clinically early relapsing–remitting multiple sclerosis. Brain 2002;125:327–37
65. TiberioM, ChardD T, AltmannD R, et al. Grey and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 2005;64:1001–7
66. ValsasinaP, BenedettiB, RovarisM, et al. Evidence for progressive grey matter loss in patients with relapsing–remitting MS. Neurology 2005;65:1126–8
67. Sastre-GarrigaJ, IngleG T, ChardD T, et al. Gray and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain 2005;128:1454–60
68. TedeschiG, LavorgnaL, RussoP, et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 2005;65:280–5
69. SanfilipoM P, BenedictR H, SharmaJ, Weinstock-GuttmanB, BakshiR. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction. NeuroImage 2005;26:1068–77
70. De StefanoN, MatthewsP M, FilippiM, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157–62
71. AmatoM P, BartolozziM L, ZipoliV, et al. Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment. Neurology 2004;63:89–93
72. BenedictR H, BruceJ M, DwyerM G, et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006;63:1301–6
73. ChenJ T, NarayananS, CollinsD L, et al. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NeuroImage 2004;23:1168–75
74. SailerM, FischlB, SalatD, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003;126:1734–44
75. BenedictR H, ZivadinovR, CaroneD A, et al. Regional lobar atrophy predicts memory impairment in multiple sclerosis. Am J Neuroradiol 2005;26:1824–31
76. PaganiE, RoccaM A, GalloA, et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. Am J Neuroradiol 2005;26:341–6
77. PrinsterA, QuarantelliM, OreficeG, et al. Grey matter loss in relapsing–remitting multiple sclerosis: a voxel-based morphometry study. NeuroImage 2006;29:859–67
78. MorgenK, SammerG, CourtneyS M, et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS. NeuroImage 2006;30:891–8
79. MesarosS, RovarisM, PaganiE, et al. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008;65:1223–30
80. MesarosS, RoccaM A, AbsintaM, et al. Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 2008;70:1107–12
81. Lycklama à NijeholtG J, BergersE, KamphorstW, et al. Postmortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 2001;124:154–66
82. GilmoreC P, DeLucaG C, BoL, et al. Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch Neurol 2005;62:1859–62
83. Lycklama à NijeholtG J, ThompsonA, FilippiM, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2003;2:555–62
84. KendiA T, TanF U, KendiM, et al. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 2004;46:764–9
85. CiccarelliO, Wheeler-KingshottC A, McLeanM A, et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007;130:2220–31
86. AgostaF, PaganiE, CaputoD, FilippiM. Associations between cervical cord gray matter damage and disability in patients with multiple sclerosis. Arch Neurol 2007;64:1302–5